Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Boehringer Ingelheim
AstraZeneca
Baxter
Colorcon
Mallinckrodt

Last Updated: December 8, 2019

DrugPatentWatch Database Preview

Litigation Details for Adare Pharmaceuticals, Inc. v. Inventia Healthcare Limited (D. Del. 2018)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Adare Pharmaceuticals, Inc. v. Inventia Healthcare Limited (D. Del. 2018)

Docket   Start Trial Date Filed 2018-07-20
Court District Court, D. Delaware Date Terminated 2019-03-18
Cause 35:271 Patent Infringement Assigned To Mitchell S. Goldberg
Jury Demand Plaintiff Referred To
Parties ADARE PHARMACEUTICALS, INC.; INVENTIA HEALTHCARE LIMITED; TEVA PHARMACEUTICALS INTERNATIONAL GMBH
Patents 7,544,372; 7,790,199; 7,820,203; 7,829,121; 8,877,245; 9,375,410; 9,399,025
Attorneys Aaron M. Nelson; Christopher P. Galligan; Dominick T. Gattuso; John R. Lane; Jonathan E Singer; Kelly A Del Dotto; Rachel P. Waldron; Susan E. Morrison; William A. Rakoczy
Firms Fish & Richardson; Heyman Enerio Gattuso & Hirzel LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Adare Pharmaceuticals, Inc. v. Inventia Healthcare Limited
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Adare Pharmaceuticals, Inc. v. Inventia Healthcare Limited (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 18 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,387,793 B2 ;US 7,544,372 B2 ;US 7,…7,829,121 B2 ;US 8,877,245 B2 . (Attachments: # 1 Patent/Trademark Report (Part 2))(Gattuso, Dominick) (…2018 18 March 2019 1:18-cv-01079 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 4 Patent/Trademark Report to Commissioner of Patents Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 9,399,025 B2; US 9,375,410 B2. (ceg)…2018 18 March 2019 1:18-cv-01079 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Colorcon
Harvard Business School
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.